Treatment of radiation-associated angiosarcoma
Armelle Dufresne1, Pierre Meeus2, Marie-Pierre Sunyach3
1Department of Medical Oncology.
Current Opinion in Oncology
|May 24, 2023
Summary
Radiation-associated angiosarcoma is a rare skin cancer requiring new treatments. Current therapies vary, and immunotherapy shows promise, but further research is essential.
Area of Science:
- Oncology
- Dermatology
- Sarcoma Research
Background:
- Radiation-associated angiosarcoma is a rare, aggressive cutaneous tumor with limited study.
- Effective therapeutic strategies for this condition are urgently needed.
Approach:
- Review of current treatment modalities including surgery, re-irradiation, and systemic therapies.
- Exploration of emerging treatments, particularly immunotherapy.
- Discussion of challenges in clinical trial design due to disease rarity and treatment heterogeneity.
Key Points:
- Complete surgical resection is the primary treatment for localized disease, but challenging with diffuse infiltration.
- Systemic treatments show efficacy in metastatic and neoadjuvant settings, though comparisons are lacking.
- Immunotherapy is the most promising future treatment avenue.
Conclusions:
- There is a significant need for comparative studies to determine the most effective treatment regimens.
- International collaborative clinical trials are crucial to overcome rarity and heterogeneity.
- Further research into immunotherapy is warranted to establish a reference treatment arm.
